8th Asian Oncology Summit (AOS), March 3-6, 2016, Kyoto, Japan

posted 22 Oct 2015, 09:06 by HKNOS .org.hk   [ updated 23 Oct 2015, 02:29 ]

Please see below for information on the 2016 Asian Oncology Summit.

 

Conference title:       

Translating Science into Medicine

8th Annual Asian Oncology Summit, 12th Annual Conference of the OOTR, Kyoto Breast Cancer Consensus Conference 2016

Westin Miyako, Kyoto, Japan

Dates:                     

March 3-6, 2016

 

Location:                  

Westin Miyako, Kyoto, Japan

 

Special delegate rate for members of Supporting Societies

US$400

 

Deadline for submission of abstracts

December 11, 2015

 

Website:  

www.asianoncologysummit.com

 

Secretariat:

Marie-Claire Morley, Asian Oncology Summit 2016. Email: m.morley@elsevier.com

 

Synopsis:

 

Special member rates are available for delegates attending the Asian Oncology Summit 2016. To qualify: select the member rate and society name during online registration.

 

The 2016 Asian Oncology Summit will be held in conjunction with the Annual Conference of the Organisation for Oncology and Translational Research (OOTR) and the Kyoto Breast Cancer Consensus Conference (KBCCC) 2016.

The 2016 meeting will comprise joint and parallel streams, each dedicated to different subspecialties within each conference and will offer a didactic overview on the trends, management, and challenges faced within the Asian context. The programme will have plenary lectures by renowned international and regional speakers, and will also feature oral and poster presentations of submitted abstracts.

This conference will offer a rare opportunity for oncologists in Asia to come together in an accessible location for interaction with, and learning from, regional opinion leaders and key oncologists from around the world. We hope the mix of speakers will facilitate an authoritative discussion on the local challenges in the field of oncology, and offer an opportunity to develop a consensus on the most appropriate treatment regimens and interventions needed to tackle the growing cancer burden in Asia.


Comments